Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532435 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL872892 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL3270977 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL3508513 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL27565987 | 0.81 | LMNA (0.50) | LMNA | |
| SCHEMBL16902064 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL16902072 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL26001345 | 0.78 | LPAR2 (0.47) | LMNALPAR2LPAR3LPAR1NR1I2 | |
| SCHEMBL3673217 | 0.78 | LMNA (0.46) | LMNA | |
| SCHEMBL3673215 | 0.78 | LMNA (0.46) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| EP-4496468-A1 | FRAGRANCES AS UREASE INHIBITORS | Symrise AG (DE) | 2025-01-29 | — | — | EP | claimed |
| CN-118922068-A | Perfume as urease inhibitor | 西姆莱斯股份公司 | 2024-11-08 | — | — | CN | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| US-20230340374-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| WO-2023179884-A1 | FRAGRANCES AS UREASE INHIBITORS | SYMRISE AG (DE) | 2023-09-28 | — | — | WO | claimed |
| US-20230166230-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | GIVAUDAN SA (CH) | 2023-06-01 | — | — | US | claimed |
| EP-4157203-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | Givaudan SA (CH) | 2023-04-05 | — | — | EP | claimed |
| US-20230084046-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | GIVAUDAN SA (CH) | 2023-03-16 | — | — | US | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089318-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090558-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089462-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| CN-1853603-B | Stable composition for hair dye | TAKASAGO PERFUMERY CO LTD | 2014-02-12 | — | — | CN | claimed |
| US-7399318-B2 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-15 | — | — | US | claimed |
| CN-1853603-A | Stable composition for hair dye comprising a fragrance | TAKASAGO PERFUMERY CO LTD (JP) | 2006-11-01 | — | — | CN | claimed |
| EP-1714637-A2 | Stable composition for hair dye comprising a fragrance | Takasago International Corporation (JP) | 2006-10-25 | — | — | EP | claimed |
| US-20060218730-A1 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | LMNA 4565/4885LPAR2 3833/4885LPAR3 3096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.